GuidelineCurrent oncology (Toronto, Ont.)2021

Evaluation and Management of Dyslipidemia in Patients Treated with Lorlatinib.

Normand Blais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.